Gelonghui, December 19 | Truist Securities: Downgraded Pfizer's Target Price from $36 to $32, maintaining a 'Buy' rating. (Gelonghui)
Truist下调辉瑞目标价至32美元
Truist has lowered the Target Price for Pfizer to 32 dollars.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated